ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 185 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,388,000 | -63.0% | 54,000 | -62.5% | 0.79% | +24.6% |
| Q2 2021 | $3,756,000 | -42.5% | 144,000 | -22.2% | 0.63% | -47.9% |
| Q1 2021 | $6,536,000 | +24.0% | 185,142 | -11.3% | 1.21% | +96.4% |
| Q4 2020 | $5,270,000 | -23.6% | 208,798 | +14.1% | 0.62% | -48.4% |
| Q3 2020 | $6,901,000 | -31.4% | 183,000 | -22.2% | 1.20% | -54.5% |
| Q2 2020 | $10,067,000 | +1539.6% | 235,098 | +643.8% | 2.63% | +1711.0% |
| Q1 2020 | $614,000 | -32.1% | 31,608 | -9.2% | 0.14% | -30.0% |
| Q4 2019 | $904,000 | -69.1% | 34,811 | -67.6% | 0.21% | -62.2% |
| Q3 2019 | $2,928,000 | -59.0% | 107,441 | -59.6% | 0.55% | -38.4% |
| Q2 2019 | $7,149,000 | -49.6% | 266,269 | -45.7% | 0.89% | -56.6% |
| Q1 2019 | $14,179,000 | -18.9% | 490,438 | -24.5% | 2.05% | -43.7% |
| Q4 2018 | $17,494,000 | – | 649,607 | – | 3.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |